SCHEMBL6618554

SCHEMBL6618554

N#C[C@@H]1C[C@H]2CCC[C@@H](C1)N2Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
CHRM2 P08172 1/20 0.50
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
USP2 O75604 1/20 0.48
OPRK1 P41145 3/20 0.47
ALDH1A1 P00352 3/20 0.46
PLA2G1B P04054 1/20 0.44
ALPL P05186 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618555 1.00 LMNA (0.50) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL5351903 0.94 CHRM2 (0.53) CHRM2CHRM4CHRM5KMT2AL3MBTL1
SCHEMBL4521492 0.94 CHRM2 (0.53) CHRM2CHRM4CHRM5KMT2AL3MBTL1
SCHEMBL25079048 0.89 CHRM2 (0.59) LMNACHRM2CHRM4CHRM5KMT2A
Potassium Ion SCHEMBL30029003 0.87 KMT2A (0.47) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL7690095 0.86 CXCR6 (0.48) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL8913176 0.83 CHRM2 (0.49) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL4870895 0.81 CHRM2 (0.60) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL1723411 0.79 CHRM2 (0.58) LMNACHRM2CHRM4CHRM5KMT2A
SCHEMBL5728905 0.79 CHRM2 (0.58) LMNACHRM2CHRM4CHRM5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944627-B1 8-AZABICYCLO 3.2.1]OCTANE-, 8-AZABICYCLO 3.2.1]OCT-6-ENE-, 9-AZABICYCLO 3.3.1]NONANE-, 9-AZA-3-OXABICYCLO 3.3.1]NONANE- AND 9-AZA-3-THIABICYCLO 3.3.1]NONANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INSECTICIDES SYNGENTA LTD (GB) 2004-02-18 EP disclosed
US-20020061913-A1 Bicyclic amine derivatives SYNGENTA LIMITED (GB) 2002-05-23 US disclosed
US-6291474-B1 COMBATING AND CONTROLLING INSECT, ACARINE OR NEMATODE PESTS ZENECA LIMITED (GB) 2001-09-18 US disclosed
US-6177442-B1 INSECTICIDES; PESTICIDES; MITICIDES; NEMATOCIDES ZENECA LIMITED (GB) 2001-01-23 US disclosed
US-5968947-A INSECTICIDES, ACARICIDES, NEMATOCIDES ZENECA LIMITED (GB) 1999-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061913-A1 Bicyclic amine derivatives ADRA1D, TAAR1, ADRA1A LMNA 2203/4885CHRM2 123/4885CHRM4 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.